Republicans introduced a bill to abolish Medicare's Independent Payment Advisory Board (IPAB) before it even gets off the ground
High-ranking Senate Republicans introduced a bill late in the summer to proactively abolish Medicare's Independent Payment Advisory Board (IPAB) before it even gets off the ground. The board will begin work in 2014, but it's already mired in political wrangling.
"IPAB is the salt in the soup," says Dan Mendelson, CEO of advisory firm Avalere Health. "You've got MedPAC, you have Congress, and three or four important elements in monitoring and controlling Medicare spending, but there is no budget for Medicare."
However, the industry will have to wait and see whom Congress and the president will appoint to the 15-member IPAB group before getting a feel for how it will approach policies-particularly policies that call for provider payment reductions. IPAB can't change eligibility rules or benefits, and up until 2020, it also won't be able to make changes to hospital payments.
"The major flaw in how Congress has set up IPAB is the exemption of hospitals from the recommendations," Mendelson says. "It's impossible to imagine controlling Medicare spending but not being able to touch 40% of that spending. They have to be able to focus on the full range of healthcare costs, and hospitals are a linchpin in reform."
IPAB will enact cuts if Medicare spending exceeds a prescribed formula.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More